Why did GALE.SW stock fall on 25 Feb 2026?

GALE.SW stock fell **6.29%** on 25 Feb 2026 mainly due to profit-taking and higher volume ahead of Galenica’s earnings on 10 Mar 2026. Traders reduced exposure after recent gains and the Healthcare sector’s cautious tone amplified the move.

What is Meyka AI’s forecast for GALE.SW stock?

Meyka AI's forecast model projects a one‑year price of **CHF108.62** for GALE.SW stock, implying **+13.86%** upside from **CHF95.40**. Forecasts are model projections and not guarantees.

Is GALE.SW stock undervalued compared with peers?

On P/E of **24.72**, GALE.SW stock trades below the Healthcare average P/E of **35.02**, suggesting relative valuation support. However, investors should factor margins, net debt and growth before judging undervaluation.

What near-term levels should traders watch for GALE.SW stock?

Traders should watch intraday support **CHF93.50**, the 50‑day average **CHF97.97** as resistance, and the quarterly model level **CHF102.56**. A breakdown under **CHF90.00** would raise downside risk.

CH Stocks

GALE.SW Galenica AG (SIX) down 6.29% on 25 Feb 2026 Market Closed: key levels to watch

ByHuzaifa Zahoor February 26, 2026

We saw GALE.SW stock drop 6.29% to CHF95.40 at market close on 25 Feb 2026, making it one of the top losers on the SIX Switzerland session. The move came on volume of 189,224 shares, almost double the average volume of 99,146, suggesting broad selling interest. Investors face an earnings report due 10 Mar 2026, and traders appear to be reducing exposure ahead of guidance. In this note we break down price action, valuation, technicals and a model forecast to help frame the near-term outlook.